1.08B
Market cap
53.55x
Current P/E
Forward P/E

About

Health care
Sector
Pharmaceuticals - Biotechnology & Life Sciences
Industry

Cosmo Pharmaceuticals N. V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy.

Similar securities

Based on sector and market capitalization

Report issue